BioStamp RC Login
Press & Media Download Now
Download MC10's Press Kit

Press & Media

October 27, 2020

Medidata Acquires Digital Biomarker Business of MC10, Enhancing Remote Biometric Data Capture Capabilities in Hybrid and Virtual Clinical Trials

NEW YORK -- (BUSINESS WIRE) -- Medidata, a Dassault Systèmes company, the global leader in creating end-to-end solutions to support the entire...

December 30, 2019

LabCorp and Covance Connect Sponsors with Patients Virtually with an Expanded Suite of Decentralized Trial Solutions

*Recent announcement from LabCorp and Covance. LabCorp is an investor and strategic partner of MC10*

November 13, 2019

MC10 Announces the Use of BioStamp nPoint® in Phase III Study of Huntington Disease

Lexington, Mass. -- (BUSINESS WIRE) -- MC10, Inc., the developer of BioStamp nPoint®, an end-to-end system for physiological data collection and...

October 24, 2019

MC10 and University of Vermont Announce Partnership to Advance Understanding of Gait Abnormalities in Movement Disorders

LEXINGTON, Mass. & BURLINGTON, Vt. -- (BUSINESS WIRE) -- MC10, Inc., the developer of BioStamp nPoint, an end-to-end system for physiological data...

October 16, 2019

MC10, Inc. Announces Collaboration with Northwestern University and Ann & Robert H. Lurie Children’s Hospital of Chicago: Innovating Precision Medicine Approaches to Improve Maternal-Infant Outcomes

Lexington, MA – MC10, Inc., the company that developed the BioStamp nPoint® System, Northwestern University’s Center for Bio-Integrated Electronics...

October 02, 2019

MC10, Inc. Announces Collaboration with University of Rochester: Development of Novel Digital Biomarkers for Central Nervous System Diseases

ROCHESTER, NY, and LEXINGTON, MA – (Business Wire) MC10, Inc., creators of the innovative wearable device BioStamp nPoint, and the University of...

May 14, 2019

MC10, Inc. and AbbVie (NYSE:ABBV) Announce Clinical Trials in Multiple Sclerosis Using the BioStamp nPoint® System

LEXINGTON, Mass. and NORTH CHICAGO, Ill. –  (BUSINESS WIRE) MC10, Inc., a healthcare technology company specializing in wearable digital health...

May 17, 2018

MC10 Receives FDA 510(k) Clearance for the BioStamp nPoint™ System

Lexington, MA MC10 Inc., the company developing wearable systems for seamless healthcare data collection, announced today that their BioStamp nPoint™...

November 01, 2017

MC10 Enters Strategic Collaboration with LabCorp (NYSE: LH), Including Equity Investment, to Advance Clinical Trial Innovation and Healthcare Diagnostics

MC10’s BioStamp® Sensor Technology promises to revolutionize clinical researcher’s ability to assess real-world physiological data.